Amicus Therapeutics, Inc.

Sümbol: FOLD

NASDAQ

10.4

USD

Turuhind täna

-20.1432
P/E suhe
-0.2119
PEG suhe
3.08B
MRK Cap
0.00%
DIV tootlus

Amicus Therapeutics, Inc. (FOLD) Finantsaruanded

Q: Mis on Amicus Therapeutics, Inc. (FOLD) koguvara?

Amicus Therapeutics, Inc. (FOLD) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Amicus Therapeutics, Inc. (FOLD) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 82.563 M, mis on 2.107 % gowth. Kogu perioodi keskmine brutokasum on 73.385 M, mis on 2.112 %. Keskmine brutokasumi suhtarv on 0.711 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.359 %, mis on võrdne -0.515 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Amicus Therapeutics, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.074. Käibevara valdkonnas on FOLD aruandlusvaluutas 483.061. Märkimisväärne osa neist varadest, täpsemalt 286.2, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust -0.025%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 3.083, kui neid on, aruandlusvaluutas. See näitab erinevust -28.336% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 387.858 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.016%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 160.174 aruandlusvaluutas. Selle aspekti aastane muutus on 0.302%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 87.632, varude hind on 59.7 ja firmaväärtus 197.8, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 20.49. Kontovõlad ja lühiajalised võlad on vastavalt 15.12 ja 8.32. Koguvõlg on 445.06, netovõlg on 198.06. Muud lühiajalised kohustused moodustavad 131.81, mis lisandub kohustuste kogusummale 617.71. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2003
balance-sheet.row.cash-and-short-term-investments	1099.23	286.2	293.6	482.5	483.3	452.7	504.2	358.6	330.4	214	151.7	82	99.1	55.7	107.4	78.2	121.1	161.5	54.7	24.4	0
balance-sheet.row.short-term-investments	217.01	39.2	144.8	237.3	320	309.9	424.4	309.5	143.3	144.5	127.6	38.4	65.2	30	77.9	58.9	93.1	117.3	42.6	18	0
balance-sheet.row.net-receivables	292.86	87.6	66.2	52.7	46.9	33.3	22	9.5	1.3	0	0	0.8	3.2	5	0	0	0	0	0	0	0
balance-sheet.row.inventory	195.02	59.7	23.8	26.8	19.6	14	8.4	4.6	3.4	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	191.73	49.5	40.2	34.8	29.7	20	16.6	19.3	5	2.6	2.9	5.5	2.3	5.9	2.2	2.3	2.5	1.5	0.3	0.4	0
balance-sheet.row.total-current-assets	1778.84	483.1	423.8	596.8	579.5	520.1	551.1	392	340.1	216.6	154.6	88.3	104.6	66.6	109.7	80.5	123.6	163	55	24.9	0
balance-sheet.row.property-plant-equipment-net	236.73	58	60.3	63.1	67.2	81	11.4	9.1	9.8	6.2	2.8	4.1	5	2.4	2.6	4.4	4.9	3.8	4.4	3.3	0
balance-sheet.row.goodwill	791.19	197.8	197.8	197.8	197.8	197.8	197.8	197.8	197.8	197.8	11.6	11.6	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	86.92	20.5	23	23	23	23	23	23	486.7	486.7	23	23	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	878.11	218.3	220.8	220.8	220.8	220.8	220.8	220.8	684.5	684.5	34.6	34.6	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	13.44	3.1	4.3	-4.9	-4.9	-5.1	-6.5	-6.5	-173.8	0	17.5	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	-10.36	0	4.9	4.9	4.9	5.1	6.5	6.5	173.8	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	75.82	15.5	10	24.4	19.1	28.3	6.7	5.2	2.5	1.1	0.5	0.6	0.4	0.7	0.3	0.5	0.3	0.3	0.3	0.5	0
balance-sheet.row.total-non-current-assets	1193.74	294.8	300.4	308.3	307.1	330.1	238.9	235.1	696.8	691.8	55.4	39.3	5.5	3.1	2.9	4.9	5.2	4.1	4.6	3.8	0
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5
balance-sheet.row.total-assets	2972.58	777.9	724.2	905.1	886.5	850.2	790	627	1036.8	908.4	210	127.6	110.1	69.8	112.6	85.4	128.8	167.1	59.6	28.7	0.5
balance-sheet.row.account-payables	76.76	15.1	15.4	21.5	17.1	120.4	80.6	7.9	41	16.5	16.3	2.1	8.8	2.6	0	0	8.8	0.5	1.2	0.9	0
balance-sheet.row.short-term-debt	31.93	8.3	8.6	7.4	6.9	7.2	0	0.3	0.3	0	3.8	0.3	0.4	1	1.3	1.6	0.9	1.5	1.3	0.3	0
balance-sheet.row.tax-payables	12.43	12.4	5.9	6.2	11.2	7.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	1722.72	387.9	443.6	432.7	434.9	203	321.7	164.2	154.5	41.6	10.5	14.2	0.3	0	1	2.3	0.3	1.2	2.3	0.7	0
Deferred Revenue Non Current	17.72	0	4.7	7.3	24.3	31.6	29.9	31.2	235.5	269.1	47.3	47.3	0	19	25.6	0	44	46.8	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-17.72	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	513.63	131.8	110.1	117.1	104.2	0	5.5	61.9	0.3	57.1	10.5	8	6.7	7.1	8.3	9.6	0	9.9	7.7	1.4	0
balance-sheet.row.total-non-current-liabilities	1830.25	450	462.1	451.8	470.5	245	360.9	204.1	565.7	486.9	67.6	71.4	31.6	20.9	31.4	2.3	44.4	48	127	61.9	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8
balance-sheet.row.capital-lease-obligations	227.27	48.9	60.1	50.8	52.5	60.7	0	0.3	0.3	0	0	0	0	0	0	0.4	0.3	1.2	2.3	0.7	0
balance-sheet.row.total-liab	2465.01	617.7	601.1	597.8	600.1	373.8	447	274.2	676.7	560.5	87.8	81.8	40.9	40.2	47.6	13.5	57.7	63.8	137.2	64.5	5.8
balance-sheet.row.preferred-stock	6.77	0	0	0	0	0	0	0	778.1	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	11.48	2.9	2.8	2.8	2.6	2.6	1.9	1.7	1.5	1.3	1	0.7	0.6	0.4	0.4	0.3	0.3	0.3	0.1	0	0
balance-sheet.row.retained-earnings	-10548.38	-2684.1	-2532.5	-2295.9	-2045.5	-1768.6	-1412.2	-1063.6	-779.6	-579.6	-447.4	-378.5	-318.9	-270.1	-225.7	-170.8	-164.2	-124.8	-83.7	-37.3	-8.5
balance-sheet.row.accumulated-other-comprehensive-income-loss	-4.04	5.3	-12.1	5	8.2	2.8	0.1	-2.1	2	-0.1	-0.1	0	0	0	0	0	0.5	0.4	0	-2.6	0
balance-sheet.row.other-total-stockholders-equity	11041.73	2836	2664.8	2595.5	2321	2239.6	1753.1	1416.8	358.1	926.2	568.7	423.6	387.5	299.3	290.2	242.3	234.4	227.4	6.1	4	3.2
balance-sheet.row.total-stockholders-equity	507.56	160.2	123	307.4	286.4	476.4	342.9	352.9	360.2	347.8	122.2	45.8	69.2	29.6	64.9	71.8	71	103.3	-77.5	-35.8	-5.3
balance-sheet.row.total-liabilities-and-stockholders-equity	2972.58	777.9	724.2	905.1	886.5	850.2	790	627	1036.8	908.4	210	127.6	110.1	69.8	112.6	85.4	128.8	167.1	59.6	28.7	0.5
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	507.56	160.2	123	307.4	286.4	476.4	342.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	2972.58	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	220.09	42.3	144.8	237.3	320	309.9	424.4	309.5	143.3	144.5	145.1	38.4	65.2	30	77.9	58.9	93.1	117.3	42.6	18	0
balance-sheet.row.total-debt	1803.53	445.1	452.1	440.1	441.7	210.2	321.7	164.5	154.5	41.6	14.3	14.5	0.7	1	2.3	3.9	1.2	2.7	3.6	1	0
balance-sheet.row.net-debt	921.3	198.1	303.3	194.9	278.5	67.4	242	115.4	-32.6	-27.9	-9.7	-29.2	-33.3	-24.6	-27.2	-15.4	-26.9	-41.5	-8.6	-5.4	0

Rahavoogude aruanne

Amicus Therapeutics, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.551 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 103.21, mis tähistab 3.659 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 49.2 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli 98064000.000. See on 0.062 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 7.87, 0, -20.96, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte 0 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -20.57, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006
cash-flows.row.net-income	-151.58	-151.6	-236.6	-250.5	-276.9	-356.4	-349	-284	-200	-132.1	-68.9	-59.6	-48.8	-44.4	-54.9	-6.6	-39.4	-41.2	-46.3	-20
cash-flows.row.depreciation-and-amortization	7.87	7.9	5.3	6.2	8.8	4.8	4.2	3.6	3.2	1.8	1.5	1.7	1.7	1.6	2.1	2.1	1.5	1.2	1	0.7
cash-flows.row.deferred-income-tax	-9.97	-4.9	0	0	-0.2	-1.4	6	-167.3	-3.7	1	0	-0.9	0	0	0.1	0	-6.4	-2.8	0	0
cash-flows.row.stock-based-compensation	86.08	86.1	76.5	57.8	49.2	44.4	29.3	23.1	17.5	10	6	6.2	6.2	8.7	6.2	7.8	6.4	2.8	0	0
cash-flows.row.change-in-working-capital	-40.05	-48	-39.9	-18.6	-32.1	11.6	-4.7	-25.8	1.1	14.3	9.4	4.9	7.8	-12.5	31.2	-46.9	-5.5	51	7	0.8
cash-flows.row.account-receivables	-20.11	-20.1	-17.3	-8.2	-11.2	-11.1	-13.3	-7.7	-1.4	0	1.1	2.5	1.8	0	0	0	0	0	0	0
cash-flows.row.inventory	-44.61	-44.6	-5.3	-7.8	-4.6	-5.1	-4.2	-0.9	-3.7	0	2.3	-3.2	3.6	0	0	0	0	0	0	0
cash-flows.row.account-payables	49.19	49.2	-6.4	7.4	-10.6	46.7	17.1	12.6	7.1	15.5	6.2	-0.6	-0.9	-1.3	-1.3	-1.7	-1.7	6.6	0	0
cash-flows.row.other-working-capital	-24.53	-32.5	-10.8	-10	-5.6	-18.9	-4.3	-29.7	-0.9	-1.1	-0.2	6.3	3.2	-11.2	32.5	-45.2	-3.8	44.4	7	0.8
cash-flows.row.other-non-cash-items	38.57	41.5	28	2.5	17.8	46.6	14.3	234.9	31.4	4.9	0.3	2	-0.6	-2.8	1.4	0.2	6.4	4.1	4.5	0.4
cash-flows.row.net-cash-provided-by-operating-activities	-69.09	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-7.44	-7.4	-3.8	-3.9	-3.2	-20	-6.3	-4.5	-6	-4.8	-0.2	-0.7	-4.3	-1.4	-0.4	-1.8	-2.7	-0.7	-2	-3
cash-flows.row.acquisitions-net	-12.2	0	3.4	3.9	3.2	20	6.3	0	0	-141.1	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-91.72	-91.7	-243.3	-341.4	-365.2	-383.9	-578.4	-490.5	-219.9	-289.6	-162.8	-56.6	-118.5	-50.6	-113.7	-98.2	-153.7	-200.7	-62	-17
cash-flows.row.sales-maturities-of-investments	197.23	197.2	335.9	424	354.8	499	463.5	323.8	221.4	290.1	55.9	83.3	83.4	98.5	94.6	131.8	178.1	126.4	37.4	3.1
cash-flows.row.other-investing-activites	12.2	0	0	-3.9	-3.2	-20	-6.3	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	98.06	98.1	92.3	78.8	-13.6	95.2	-121.2	-171.2	-4.5	-145.3	-107.1	26.1	-39.4	46.5	-19.4	31.9	21.7	-75	-26.6	-16.9
cash-flows.row.debt-repayment	-20.96	-21	-0.3	-0.5	-155.3	-0.4	-0.3	-0.3	-80.2	-15.3	-0.3	-0.4	-1.3	-1.3	-1.6	-1	0	0	0	0
cash-flows.row.common-stock-issued	95.35	103.2	4.3	199.8	42.3	189	294.6	243	97.1	243	135.8	15	80.2	45.2	45.2	0	0.5	92.8	63.6	40.4
cash-flows.row.common-stock-repurchased	-17.92	0	-11.5	-15	-10	-3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	-4.3	-15	-32.3	-3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	7.19	-20.6	4.3	42.8	418.2	35.4	156.5	4.7	255.8	63.1	3.7	14.8	2.6	-44.9	0	3.8	-1.5	-0.8	2.5	0.8
cash-flows.row.net-cash-used-provided-by-financing-activities	61.68	61.7	-7.5	212.1	262.9	217.5	450.8	247.4	272.7	290.9	139.2	29.4	81.5	-0.9	43.7	2.8	-1	91.9	66.2	41.3
cash-flows.row.effect-of-forex-changes-on-cash	6.31	6.3	-14.6	-5	3.8	1.7	1.5	1.3	-0.1	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	96.83	98.2	-96.3	83.3	19.8	64	31.1	-138	117.5	45.4	-19.6	9.7	8.3	-3.9	10.2	-8.7	-16.1	32.1	5.7	6.2
cash-flows.row.cash-at-end-of-period	892.58	247	153.1	249.5	166.2	146.3	82.4	49.1	187	69.5	24.1	43.6	34	25.7	29.6	19.3	28.1	44.2	12.1	6.4
cash-flows.row.cash-at-beginning-of-period	795.75	148.8	249.5	166.2	146.3	82.4	51.2	187	69.5	24.1	43.6	34	25.7	29.6	19.3	28.1	44.2	12.1	6.4	0.3
cash-flows.row.operating-cash-flow	-69.09	-69.1	-166.6	-202.5	-233.3	-250.4	-300	-215.5	-150.5	-100.1	-51.7	-45.8	-33.7	-49.4	-14	-43.4	-36.9	15.2	-33.9	-18.1
cash-flows.row.capital-expenditure	-7.44	-7.4	-3.8	-3.9	-3.2	-20	-6.3	-4.5	-6	-4.8	-0.2	-0.7	-4.3	-1.4	-0.4	-1.8	-2.7	-0.7	-2	-3
cash-flows.row.free-cash-flow	-76.53	-76.5	-170.3	-206.4	-236.5	-270.4	-306.3	-220	-156.5	-105	-51.9	-46.5	-38.1	-50.8	-14.4	-45.2	-39.5	14.5	-35.9	-21.2

Kasumiaruande rida

Amicus Therapeutics, Inc. tulud muutusid võrreldes eelmise perioodiga 0.213%. FOLD brutokasum on teatatud 354.16. Ettevõtte tegevuskulud on 427.65, mille muutus võrreldes eelmise aastaga on -13.616%. Kulud amortisatsioonikulud on 7.87, mis on -0.372% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 427.65, mis näitab -13.616% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 0.640% kasvu võrreldes eelmise aastaga. Tegevustulu on -73.49, mis näitab -0.640% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.359%. Eelmise aasta puhaskasum oli -151.58.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004
income-statement-row.row.total-revenue	399.36	399.4	329.2	305.5	260.9	182.2	91.2	36.9	5	0	1.2	0.4	18.4	21.4	0.9	64.4	15	1.8	0	0	0	0
income-statement-row.row.cost-of-revenue	39.51	45.2	38.6	34.5	31	22	14.4	6.2	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit	359.85	354.2	290.6	271	229.8	160.3	76.8	30.7	4.1	0	1.2	0.4	18.4	21.4	0.9	64.4	15	1.8	0	0	0	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	152.38	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-8.69	-15.9	5.3	6.2	8.8	4.8	-5.6	6	-4.8	-0.1	-0.1	1.7	0	1.6	2.1	2.1	1.5	1.2	0	0	-8.8	0
income-statement-row.row.operating-expenses	431.11	427.7	495.1	471	473.7	461	402.3	241.6	179.2	126	69.9	62.6	71.3	72.3	56.8	70.2	58.9	47.6	46.9	20.8	-8.8	6.6
income-statement-row.row.cost-and-expenses	470.62	472.9	533.7	505.4	504.7	483	416.7	247.8	180	126	69.9	62.6	71.3	72.3	56.8	70.2	58.9	47.6	46.9	20.8	-8.8	6.6
income-statement-row.row.interest-income	7.08	7.1	3	0.5	3.2	10.2	10.5	4.1	1.6	0.9	0.2	0.2	0.3	0.2	0.2	1	0	5.1	2	0.6	0	0
income-statement-row.row.interest-expense	24.18	50.1	37.1	32.5	22.4	18.9	22.4	17.2	5.4	1.6	1.5	0	0.1	0.1	0.3	0.3	0	-0.3	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-63.86	-76.6	-37.6	-41.6	-30.4	-55.2	-11.7	-225.1	-24.9	-5.4	-0.1	-1.1	0.7	2.8	-0.1	-1.5	4.6	-0.1	-1.2	-0.3	0	-0.2
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-8.69	-15.9	5.3	6.2	8.8	4.8	-5.6	6	-4.8	-0.1	-0.1	1.7	0	1.6	2.1	2.1	1.5	1.2	0	0	-8.8	0
income-statement-row.row.total-operating-expenses	-63.86	-76.6	-37.6	-41.6	-30.4	-55.2	-11.7	-225.1	-24.9	-5.4	-0.1	-1.1	0.7	2.8	-0.1	-1.5	4.6	-0.1	-1.2	-0.3	0	-0.2
income-statement-row.row.interest-expense	24.18	50.1	37.1	32.5	22.4	18.9	22.4	17.2	5.4	1.6	1.5	0	0.1	0.1	0.3	0.3	0	-0.3	0	0	0	0
income-statement-row.row.depreciation-and-amortization	4.13	7.9	12.5	3.8	11.3	-28.2	4.2	3.6	3.2	1.8	1.5	1.7	1.7	1.6	2.1	2.1	1.5	1.2	1	0.7	0	0.1
income-statement-row.row.ebitda-caps	-94.93	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-76.96	-73.5	-204.4	-199.9	-243.9	-300.7	-328.8	-442	-181.9	-130.4	-68.7	-64.2	-52.9	-50.9	-55.8	-7.3	-44	-45.8	-46.9	-20.8	-8.8	-6.6
income-statement-row.row.income-before-tax	-150.1	-150.1	-242	-241.6	-274.3	-355.9	-349.1	-449.1	-203.8	-132.1	-70	-63.1	-52	-48	-56.1	-6.6	-39.4	-41.2	-46.3	-20.6	0	-6.8
income-statement-row.row.income-tax-expense	7.74	1.5	-5.5	8.9	2.6	0.5	-0.1	-165.1	-3.7	1.5	-1.1	-3.5	-3.2	-3.6	-1.1	0.3	0	0.4	-0.5	-0.6	8.8	0
income-statement-row.row.net-income	-151.58	-151.6	-236.6	-250.5	-276.9	-356.4	-349	-284	-200	-132.1	-68.9	-59.6	-48.8	-44.4	-54.9	-6.6	-39.4	-41.2	-46.3	-20	-8.8	-6.8